PEOPLE - Metasyn adds four executives to senior management team:
This article was originally published in Clinica
Metasyn, a US imaging agent company, has recently added four executives to its senior management team. Dr Stanley Crooke, founder, chairman and CEO of Isis Pharmaceuticals, has joined Metasyn's board of directors, and is named chairman of its scientific advisory board. Dr James Smith becomes executive vice-president of development. He was formerly senior director of radiopharmaceutical R&D with DuPont Merck Pharmaceutical. Dr Kent Yucel is named senior vice-president and chief medical officer. Prior to this he was chief of vascular and interventional radiology and director of MRI at Boston University Medical Centre. Dr Stephen Knight is appointed vice-president of strategic planning and corporate development. He was previously a senior manager in the healthcare practice Arthur D Little.
You may also be interested in...
The company will use the proceeds to fund clinical trials, expand commercialization of its targeted radiation therapy, and file for CE marking in Europe.
Advanced Medical Solutions said it will buy Raleigh Adhesive Coatings for £22m ($29m) in cash to strengthen its overall wound care business.
While Amgen said the Phase III GALACTIC-HF results for omecamtiv mecarbil did not meet its high expectations for the heart failure candidate, Cytokinetics sees a path to treating certain patients.